Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use

被引:62
作者
van der Linden, FAH
Kragt, JJ
Klein, M
van der Ploeg, HM
Polman, CH
Uitdehaag, BMJ
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Neurol, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, NL-1007 MB Amsterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Dept Clin Epidemiol & Biostat, NL-1007 MB Amsterdam, Netherlands
关键词
D O I
10.1136/jnnp.2005.065227
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: There may be difficulties in the use of self report measurements in patients with cognitive impairment or serious mood disturbances which interfere with reliable self assessment, as may be the case in multiple sclerosis (MS). In such cases proxies may provide valuable information. However, before using any questionnaires in a proxy sample, the questionnaire should be evaluated for proxy use. Objective: To evaluate the psychometric properties of the 29 item Multiple Sclerosis Impact Scale (MSIS-29) when used by proxies of MS patients. Methods: A sample of 62 partners of MS patients completed the MSIS-29. The data were evaluated for the psychometric criteria of the MSIS-29, including data quality, scaling assumptions, acceptability, reliability, validity, and responsiveness. Results: Psychometric evaluation was satisfactory; data quality was high, and scaling assumptions and acceptability were good. Reliability was high (alpha > 0.80). Findings were consistent with results of a psychometric evaluation in a patient sample. Conclusions: The MSIS-29 can be used reliably in proxies of patients with MS. As a next step the relation between data obtained from patients and proxies needs to be studied, focusing on factors that may affect agreement and discrepancies.
引用
收藏
页码:1677 / 1681
页数:5
相关论文
共 21 条
[1]   Reliable screening for neuropsychological impairment in multiple sclerosis [J].
Benedict, RHB ;
Cox, D ;
Thompson, LL ;
Foley, F ;
Weinstock-Guttman, B ;
Munschauer, F .
MULTIPLE SCLEROSIS JOURNAL, 2004, 10 (06) :675-678
[2]   Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis [J].
Benedict, RHB ;
Fishman, I ;
McClellan, MM ;
Bakshi, R ;
Weinstock-Guttman, B .
MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (04) :393-396
[3]   Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire [J].
Benedict, RHB ;
Munschauer, F ;
Linn, R ;
Miller, C ;
Murphy, E ;
Foley, F ;
Jacobs, L .
MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (01) :95-101
[4]   Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures [J].
Gold, SM ;
Schulz, H ;
Mönch, A ;
Schulz, KH ;
Heesen, C .
MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (04) :404-410
[5]   The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis [J].
Goverover, Y ;
Chiaravalloti, N ;
DeLuca, J .
MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (02) :203-212
[6]   Self-report measures of patient utility: should we trust them? [J].
Hanita, M .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2000, 53 (05) :469-476
[7]  
HOBART JC, 2003, MULT SCLER S1, V9, P23, DOI DOI 10.1177/135245850300900101
[8]  
HOBART JC, 2004, HEALTH TECHNOL ASSES, P8
[9]   Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis [J].
Janssens, ACJW ;
van Doorn, PA ;
de Boer, JB ;
Kalkers, NF ;
van der Meché, FGA ;
Passchier, J ;
Hintzen, RQ .
MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (04) :397-403
[10]   DETERMINING A MINIMAL IMPORTANT CHANGE IN A DISEASE-SPECIFIC QUALITY-OF-LIFE QUESTIONNAIRE [J].
JUNIPER, EF ;
GUYATT, GH ;
WILLAN, A ;
GRIFFITH, LE .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (01) :81-87